at 52 Weeks MariTide Delivered Substantial Improvements Across Cardiometabolic Parameters Announces "MARITIME," a Phase 3 Clinical Development Program in Obesity and Obesity-Related Conditions 1 The study also showed people living with obesity or overweight and Type 2 diabetes, who typically lose less weight on GLP-1 therapies, achieved up to ~17% average weight loss, also without a weight loss plateau, and lowered their average hemoglobin A1C (HbA1c) by up to 2.2 percentage points at week 52
Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets
Unlike hormonal birth control or fertility medications, GLP-1 drugs do not directly alter reproductive hormone production or ovarian function
Nourish skin from within for a radiant glow
The timing of injection relative to meals and other activities may influence tolerance and efficacy
When HFD fed rats were given Zingiberene at the dose of 50 mg/kg body weight it attenuates hyperlipidaemia, hyperglycemia, hyperinsulinemia in both liver and blood further, it reduces the elevated lipogenesis and oxidative stress in liver along with this it regulate activities of carnitine palmitoyl transferase, acetyl-CoA carboxylase, fatty acid synthase, and HMG CoA reductase [149]